Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5050583 | 6204454 | I | 5050583-6 | 20060615 | 20060710 | 20060713 | EXP | FR-GLAXOSMITHKLINE-B0430313A | GLAXOSMITHKLINE | 62 | YR | M | Y | 20060713 | CN | FRANCE |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5050583 | 1007464074 | PS | VALACYCLOVIR HCL | 1 | ORAL | 500MG SIX TIMES PER DAY | 20487 | ||||
| 5050583 | 1007464075 | C | AMIODARONE HCL | 1 | |||||||
| 5050583 | 1007464076 | C | CARDENSIEL | 2 | |||||||
| 5050583 | 1007464077 | C | TRIATEC | 2 | |||||||
| 5050583 | 1007464078 | C | PREVISCAN | 2 | |||||||
| 5050583 | 1007464079 | C | FUROSEMIDE | 1 | |||||||
| 5050583 | 1007464080 | C | KALEORID | 2 | |||||||
| 5050583 | 1007464081 | C | LIPANTHYL | 2 | |||||||
| 5050583 | 1007464082 | C | EQUANIL | 1 | |||||||
| 5050583 | 1007464083 | C | DIMETANE | 1 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5050583 | 1007464074 | HERPES ZOSTER |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5050583 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5050583 | ANURIA |
| 5050583 | BACK PAIN |
| 5050583 | RENAL FAILURE ACUTE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5050583 | 1007464074 | 20060610 | 20060615 | 6 | DAY |